The Drug Information Association tapped Quintiles’ J. Rick Turner as editor-in-chief of Drug Information Journal, the group’s flagship journal for members. Under Turner’s leadership, the journal will expand its coverage to medical devices and medical device and drug combination products, companion diagnostics and integrated pharmaceutical medicine, with a focus on regulatory science, according to a statement.
“While pharmaceutical medicine remains extremely important, the convergence of several lines of medical products plays a very large and potentially increasing role in improving human health in general,” Turner said in a statement.